Global Newborn Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Newborn Screening market size was valued at US$ 1116 million in 2025 and is forecast to a readjusted size of US$ 1664 million by 2032 with a CAGR of 5.9% during review period.
Newborn Screening is the organized testing and follow up workflow that checks babies shortly after birth for serious conditions that are not yet visible but can be prevented or treated if found early. From a consumer perspective, it is a safety net bundled into birth care that delivers timely results and clear next steps, minimizing anxiety through reliable communication and fast referral when a screen is abnormal. From a government perspective, it is a population health program that standardizes early detection, funds and regulates laboratory quality, ensures equitable access, and connects positive screens to treatment pathways to reduce preventable disability and long term healthcare burden.
The newborn screening market is best understood as a policy anchored healthcare utility where demand is structurally stable and competitive dynamics are shaped more by governance and operational credibility than by commercial marketing. Because outcomes depend on flawless execution across collection, laboratory processing, reporting, and follow up, buyers prioritize reliability, quality systems, and integration with maternity and pediatric care pathways, which raises barriers to entry and supports long term incumbent positions. Growth is driven primarily by program upgrades such as expanded condition coverage, greater use of molecular confirmatory methods, digitized reporting, and stronger case management, while pricing tends to be constrained by public procurement and cost effectiveness expectations. As a result, service providers differentiate through turnaround time, recall performance, data connectivity, and end to end clinical coordination rather than through test volume alone.
This report is a detailed and comprehensive analysis for global Newborn Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newborn Screening market size and forecasts, in consumption value ($ Million), 2021-2032
Global Newborn Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Newborn Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Newborn Screening market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Newborn Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Newborn Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Cordlife, BGI Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Newborn Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Newborn Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Screening, with revenue, gross margin, and global market share of Newborn Screening from 2021 to 2026.
Chapter 3, the Newborn Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Screening.
Chapter 13, to describe Newborn Screening research findings and conclusion.
Newborn Screening is the organized testing and follow up workflow that checks babies shortly after birth for serious conditions that are not yet visible but can be prevented or treated if found early. From a consumer perspective, it is a safety net bundled into birth care that delivers timely results and clear next steps, minimizing anxiety through reliable communication and fast referral when a screen is abnormal. From a government perspective, it is a population health program that standardizes early detection, funds and regulates laboratory quality, ensures equitable access, and connects positive screens to treatment pathways to reduce preventable disability and long term healthcare burden.
The newborn screening market is best understood as a policy anchored healthcare utility where demand is structurally stable and competitive dynamics are shaped more by governance and operational credibility than by commercial marketing. Because outcomes depend on flawless execution across collection, laboratory processing, reporting, and follow up, buyers prioritize reliability, quality systems, and integration with maternity and pediatric care pathways, which raises barriers to entry and supports long term incumbent positions. Growth is driven primarily by program upgrades such as expanded condition coverage, greater use of molecular confirmatory methods, digitized reporting, and stronger case management, while pricing tends to be constrained by public procurement and cost effectiveness expectations. As a result, service providers differentiate through turnaround time, recall performance, data connectivity, and end to end clinical coordination rather than through test volume alone.
This report is a detailed and comprehensive analysis for global Newborn Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newborn Screening market size and forecasts, in consumption value ($ Million), 2021-2032
Global Newborn Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Newborn Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Newborn Screening market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Newborn Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Newborn Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Cordlife, BGI Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Newborn Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Genetic Sequencing
- Hearing Screening
- Pulse Oximetry
- Others
- Core Condition Screening
- Expanded Condition Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Others
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Cordlife
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Newborn Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Screening, with revenue, gross margin, and global market share of Newborn Screening from 2021 to 2026.
Chapter 3, the Newborn Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Screening.
Chapter 13, to describe Newborn Screening research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Newborn Screening by Type
1.3.1 Overview: Global Newborn Screening Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Newborn Screening Consumption Value Market Share by Type in 2025
1.3.3 Genetic Sequencing
1.3.4 Hearing Screening
1.3.5 Pulse Oximetry
1.3.6 Others
1.4 Classification of Newborn Screening by Screening Purpose
1.4.1 Overview: Global Newborn Screening Market Size by Screening Purpose: 2021 Versus 2025 Versus 2032
1.4.2 Global Newborn Screening Consumption Value Market Share by Screening Purpose in 2025
1.4.3 Core Condition Screening
1.4.4 Expanded Condition Screening
1.5 Classification of Newborn Screening by Service Model
1.5.1 Overview: Global Newborn Screening Market Size by Service Model: 2021 Versus 2025 Versus 2032
1.5.2 Global Newborn Screening Consumption Value Market Share by Service Model in 2025
1.5.3 Public Health Program
1.5.4 Consumer
1.5.5 Others
1.6 Global Newborn Screening Market by Application
1.6.1 Overview: Global Newborn Screening Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Private Hospitals
1.6.4 Others
1.7 Global Newborn Screening Market Size & Forecast
1.8 Global Newborn Screening Market Size and Forecast by Region
1.8.1 Global Newborn Screening Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Newborn Screening Market Size by Region, (2021-2032)
1.8.3 North America Newborn Screening Market Size and Prospect (2021-2032)
1.8.4 Europe Newborn Screening Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Newborn Screening Market Size and Prospect (2021-2032)
1.8.6 South America Newborn Screening Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Newborn Screening Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Newborn Screening Product and Solutions
2.1.4 Thermo Fisher Scientific Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Revvity
2.2.1 Revvity Details
2.2.2 Revvity Major Business
2.2.3 Revvity Newborn Screening Product and Solutions
2.2.4 Revvity Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Revvity Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Newborn Screening Product and Solutions
2.3.4 Quest Diagnostics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 MedGenome
2.4.1 MedGenome Details
2.4.2 MedGenome Major Business
2.4.3 MedGenome Newborn Screening Product and Solutions
2.4.4 MedGenome Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MedGenome Recent Developments and Future Plans
2.5 Mayo Clinic Laboratories
2.5.1 Mayo Clinic Laboratories Details
2.5.2 Mayo Clinic Laboratories Major Business
2.5.3 Mayo Clinic Laboratories Newborn Screening Product and Solutions
2.5.4 Mayo Clinic Laboratories Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.6 GeneDx
2.6.1 GeneDx Details
2.6.2 GeneDx Major Business
2.6.3 GeneDx Newborn Screening Product and Solutions
2.6.4 GeneDx Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GeneDx Recent Developments and Future Plans
2.7 PreventionGenetics
2.7.1 PreventionGenetics Details
2.7.2 PreventionGenetics Major Business
2.7.3 PreventionGenetics Newborn Screening Product and Solutions
2.7.4 PreventionGenetics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 PreventionGenetics Recent Developments and Future Plans
2.8 SYNLAB
2.8.1 SYNLAB Details
2.8.2 SYNLAB Major Business
2.8.3 SYNLAB Newborn Screening Product and Solutions
2.8.4 SYNLAB Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SYNLAB Recent Developments and Future Plans
2.9 Cordlife
2.9.1 Cordlife Details
2.9.2 Cordlife Major Business
2.9.3 Cordlife Newborn Screening Product and Solutions
2.9.4 Cordlife Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cordlife Recent Developments and Future Plans
2.10 BGI Genomics
2.10.1 BGI Genomics Details
2.10.2 BGI Genomics Major Business
2.10.3 BGI Genomics Newborn Screening Product and Solutions
2.10.4 BGI Genomics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 BGI Genomics Recent Developments and Future Plans
2.11 Berry Genomics
2.11.1 Berry Genomics Details
2.11.2 Berry Genomics Major Business
2.11.3 Berry Genomics Newborn Screening Product and Solutions
2.11.4 Berry Genomics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Berry Genomics Recent Developments and Future Plans
2.12 Annaroad
2.12.1 Annaroad Details
2.12.2 Annaroad Major Business
2.12.3 Annaroad Newborn Screening Product and Solutions
2.12.4 Annaroad Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Annaroad Recent Developments and Future Plans
2.13 Jiajian Medical Testing
2.13.1 Jiajian Medical Testing Details
2.13.2 Jiajian Medical Testing Major Business
2.13.3 Jiajian Medical Testing Newborn Screening Product and Solutions
2.13.4 Jiajian Medical Testing Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Jiajian Medical Testing Recent Developments and Future Plans
2.14 Genesky
2.14.1 Genesky Details
2.14.2 Genesky Major Business
2.14.3 Genesky Newborn Screening Product and Solutions
2.14.4 Genesky Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Genesky Recent Developments and Future Plans
2.15 Weihansi Biomedical Technology
2.15.1 Weihansi Biomedical Technology Details
2.15.2 Weihansi Biomedical Technology Major Business
2.15.3 Weihansi Biomedical Technology Newborn Screening Product and Solutions
2.15.4 Weihansi Biomedical Technology Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Newborn Screening Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Newborn Screening by Company Revenue
3.2.2 Top 3 Newborn Screening Players Market Share in 2025
3.2.3 Top 6 Newborn Screening Players Market Share in 2025
3.3 Newborn Screening Market: Overall Company Footprint Analysis
3.3.1 Newborn Screening Market: Region Footprint
3.3.2 Newborn Screening Market: Company Product Type Footprint
3.3.3 Newborn Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Newborn Screening Consumption Value and Market Share by Type (2021-2026)
4.2 Global Newborn Screening Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Newborn Screening Consumption Value Market Share by Application (2021-2026)
5.2 Global Newborn Screening Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Newborn Screening Consumption Value by Type (2021-2032)
6.2 North America Newborn Screening Market Size by Application (2021-2032)
6.3 North America Newborn Screening Market Size by Country
6.3.1 North America Newborn Screening Consumption Value by Country (2021-2032)
6.3.2 United States Newborn Screening Market Size and Forecast (2021-2032)
6.3.3 Canada Newborn Screening Market Size and Forecast (2021-2032)
6.3.4 Mexico Newborn Screening Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Newborn Screening Consumption Value by Type (2021-2032)
7.2 Europe Newborn Screening Consumption Value by Application (2021-2032)
7.3 Europe Newborn Screening Market Size by Country
7.3.1 Europe Newborn Screening Consumption Value by Country (2021-2032)
7.3.2 Germany Newborn Screening Market Size and Forecast (2021-2032)
7.3.3 France Newborn Screening Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Newborn Screening Market Size and Forecast (2021-2032)
7.3.5 Russia Newborn Screening Market Size and Forecast (2021-2032)
7.3.6 Italy Newborn Screening Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Newborn Screening Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Newborn Screening Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Newborn Screening Market Size by Region
8.3.1 Asia-Pacific Newborn Screening Consumption Value by Region (2021-2032)
8.3.2 China Newborn Screening Market Size and Forecast (2021-2032)
8.3.3 Japan Newborn Screening Market Size and Forecast (2021-2032)
8.3.4 South Korea Newborn Screening Market Size and Forecast (2021-2032)
8.3.5 India Newborn Screening Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Newborn Screening Market Size and Forecast (2021-2032)
8.3.7 Australia Newborn Screening Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Newborn Screening Consumption Value by Type (2021-2032)
9.2 South America Newborn Screening Consumption Value by Application (2021-2032)
9.3 South America Newborn Screening Market Size by Country
9.3.1 South America Newborn Screening Consumption Value by Country (2021-2032)
9.3.2 Brazil Newborn Screening Market Size and Forecast (2021-2032)
9.3.3 Argentina Newborn Screening Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Newborn Screening Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Newborn Screening Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Newborn Screening Market Size by Country
10.3.1 Middle East & Africa Newborn Screening Consumption Value by Country (2021-2032)
10.3.2 Turkey Newborn Screening Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Newborn Screening Market Size and Forecast (2021-2032)
10.3.4 UAE Newborn Screening Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Newborn Screening Market Drivers
11.2 Newborn Screening Market Restraints
11.3 Newborn Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Newborn Screening Industry Chain
12.2 Newborn Screening Upstream Analysis
12.3 Newborn Screening Midstream Analysis
12.4 Newborn Screening Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Newborn Screening by Type
1.3.1 Overview: Global Newborn Screening Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Newborn Screening Consumption Value Market Share by Type in 2025
1.3.3 Genetic Sequencing
1.3.4 Hearing Screening
1.3.5 Pulse Oximetry
1.3.6 Others
1.4 Classification of Newborn Screening by Screening Purpose
1.4.1 Overview: Global Newborn Screening Market Size by Screening Purpose: 2021 Versus 2025 Versus 2032
1.4.2 Global Newborn Screening Consumption Value Market Share by Screening Purpose in 2025
1.4.3 Core Condition Screening
1.4.4 Expanded Condition Screening
1.5 Classification of Newborn Screening by Service Model
1.5.1 Overview: Global Newborn Screening Market Size by Service Model: 2021 Versus 2025 Versus 2032
1.5.2 Global Newborn Screening Consumption Value Market Share by Service Model in 2025
1.5.3 Public Health Program
1.5.4 Consumer
1.5.5 Others
1.6 Global Newborn Screening Market by Application
1.6.1 Overview: Global Newborn Screening Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Private Hospitals
1.6.4 Others
1.7 Global Newborn Screening Market Size & Forecast
1.8 Global Newborn Screening Market Size and Forecast by Region
1.8.1 Global Newborn Screening Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Newborn Screening Market Size by Region, (2021-2032)
1.8.3 North America Newborn Screening Market Size and Prospect (2021-2032)
1.8.4 Europe Newborn Screening Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Newborn Screening Market Size and Prospect (2021-2032)
1.8.6 South America Newborn Screening Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Newborn Screening Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Newborn Screening Product and Solutions
2.1.4 Thermo Fisher Scientific Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Revvity
2.2.1 Revvity Details
2.2.2 Revvity Major Business
2.2.3 Revvity Newborn Screening Product and Solutions
2.2.4 Revvity Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Revvity Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Newborn Screening Product and Solutions
2.3.4 Quest Diagnostics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 MedGenome
2.4.1 MedGenome Details
2.4.2 MedGenome Major Business
2.4.3 MedGenome Newborn Screening Product and Solutions
2.4.4 MedGenome Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 MedGenome Recent Developments and Future Plans
2.5 Mayo Clinic Laboratories
2.5.1 Mayo Clinic Laboratories Details
2.5.2 Mayo Clinic Laboratories Major Business
2.5.3 Mayo Clinic Laboratories Newborn Screening Product and Solutions
2.5.4 Mayo Clinic Laboratories Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.6 GeneDx
2.6.1 GeneDx Details
2.6.2 GeneDx Major Business
2.6.3 GeneDx Newborn Screening Product and Solutions
2.6.4 GeneDx Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 GeneDx Recent Developments and Future Plans
2.7 PreventionGenetics
2.7.1 PreventionGenetics Details
2.7.2 PreventionGenetics Major Business
2.7.3 PreventionGenetics Newborn Screening Product and Solutions
2.7.4 PreventionGenetics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 PreventionGenetics Recent Developments and Future Plans
2.8 SYNLAB
2.8.1 SYNLAB Details
2.8.2 SYNLAB Major Business
2.8.3 SYNLAB Newborn Screening Product and Solutions
2.8.4 SYNLAB Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 SYNLAB Recent Developments and Future Plans
2.9 Cordlife
2.9.1 Cordlife Details
2.9.2 Cordlife Major Business
2.9.3 Cordlife Newborn Screening Product and Solutions
2.9.4 Cordlife Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cordlife Recent Developments and Future Plans
2.10 BGI Genomics
2.10.1 BGI Genomics Details
2.10.2 BGI Genomics Major Business
2.10.3 BGI Genomics Newborn Screening Product and Solutions
2.10.4 BGI Genomics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 BGI Genomics Recent Developments and Future Plans
2.11 Berry Genomics
2.11.1 Berry Genomics Details
2.11.2 Berry Genomics Major Business
2.11.3 Berry Genomics Newborn Screening Product and Solutions
2.11.4 Berry Genomics Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Berry Genomics Recent Developments and Future Plans
2.12 Annaroad
2.12.1 Annaroad Details
2.12.2 Annaroad Major Business
2.12.3 Annaroad Newborn Screening Product and Solutions
2.12.4 Annaroad Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Annaroad Recent Developments and Future Plans
2.13 Jiajian Medical Testing
2.13.1 Jiajian Medical Testing Details
2.13.2 Jiajian Medical Testing Major Business
2.13.3 Jiajian Medical Testing Newborn Screening Product and Solutions
2.13.4 Jiajian Medical Testing Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Jiajian Medical Testing Recent Developments and Future Plans
2.14 Genesky
2.14.1 Genesky Details
2.14.2 Genesky Major Business
2.14.3 Genesky Newborn Screening Product and Solutions
2.14.4 Genesky Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Genesky Recent Developments and Future Plans
2.15 Weihansi Biomedical Technology
2.15.1 Weihansi Biomedical Technology Details
2.15.2 Weihansi Biomedical Technology Major Business
2.15.3 Weihansi Biomedical Technology Newborn Screening Product and Solutions
2.15.4 Weihansi Biomedical Technology Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Newborn Screening Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Newborn Screening by Company Revenue
3.2.2 Top 3 Newborn Screening Players Market Share in 2025
3.2.3 Top 6 Newborn Screening Players Market Share in 2025
3.3 Newborn Screening Market: Overall Company Footprint Analysis
3.3.1 Newborn Screening Market: Region Footprint
3.3.2 Newborn Screening Market: Company Product Type Footprint
3.3.3 Newborn Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Newborn Screening Consumption Value and Market Share by Type (2021-2026)
4.2 Global Newborn Screening Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Newborn Screening Consumption Value Market Share by Application (2021-2026)
5.2 Global Newborn Screening Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Newborn Screening Consumption Value by Type (2021-2032)
6.2 North America Newborn Screening Market Size by Application (2021-2032)
6.3 North America Newborn Screening Market Size by Country
6.3.1 North America Newborn Screening Consumption Value by Country (2021-2032)
6.3.2 United States Newborn Screening Market Size and Forecast (2021-2032)
6.3.3 Canada Newborn Screening Market Size and Forecast (2021-2032)
6.3.4 Mexico Newborn Screening Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Newborn Screening Consumption Value by Type (2021-2032)
7.2 Europe Newborn Screening Consumption Value by Application (2021-2032)
7.3 Europe Newborn Screening Market Size by Country
7.3.1 Europe Newborn Screening Consumption Value by Country (2021-2032)
7.3.2 Germany Newborn Screening Market Size and Forecast (2021-2032)
7.3.3 France Newborn Screening Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Newborn Screening Market Size and Forecast (2021-2032)
7.3.5 Russia Newborn Screening Market Size and Forecast (2021-2032)
7.3.6 Italy Newborn Screening Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Newborn Screening Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Newborn Screening Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Newborn Screening Market Size by Region
8.3.1 Asia-Pacific Newborn Screening Consumption Value by Region (2021-2032)
8.3.2 China Newborn Screening Market Size and Forecast (2021-2032)
8.3.3 Japan Newborn Screening Market Size and Forecast (2021-2032)
8.3.4 South Korea Newborn Screening Market Size and Forecast (2021-2032)
8.3.5 India Newborn Screening Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Newborn Screening Market Size and Forecast (2021-2032)
8.3.7 Australia Newborn Screening Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Newborn Screening Consumption Value by Type (2021-2032)
9.2 South America Newborn Screening Consumption Value by Application (2021-2032)
9.3 South America Newborn Screening Market Size by Country
9.3.1 South America Newborn Screening Consumption Value by Country (2021-2032)
9.3.2 Brazil Newborn Screening Market Size and Forecast (2021-2032)
9.3.3 Argentina Newborn Screening Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Newborn Screening Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Newborn Screening Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Newborn Screening Market Size by Country
10.3.1 Middle East & Africa Newborn Screening Consumption Value by Country (2021-2032)
10.3.2 Turkey Newborn Screening Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Newborn Screening Market Size and Forecast (2021-2032)
10.3.4 UAE Newborn Screening Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Newborn Screening Market Drivers
11.2 Newborn Screening Market Restraints
11.3 Newborn Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Newborn Screening Industry Chain
12.2 Newborn Screening Upstream Analysis
12.3 Newborn Screening Midstream Analysis
12.4 Newborn Screening Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Newborn Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Newborn Screening Consumption Value by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Table 3. Global Newborn Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Newborn Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Newborn Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Newborn Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Newborn Screening Product and Solutions
Table 10. Thermo Fisher Scientific Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Revvity Company Information, Head Office, and Major Competitors
Table 13. Revvity Major Business
Table 14. Revvity Newborn Screening Product and Solutions
Table 15. Revvity Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Revvity Recent Developments and Future Plans
Table 17. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 18. Quest Diagnostics Major Business
Table 19. Quest Diagnostics Newborn Screening Product and Solutions
Table 20. Quest Diagnostics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. MedGenome Company Information, Head Office, and Major Competitors
Table 22. MedGenome Major Business
Table 23. MedGenome Newborn Screening Product and Solutions
Table 24. MedGenome Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. MedGenome Recent Developments and Future Plans
Table 26. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 27. Mayo Clinic Laboratories Major Business
Table 28. Mayo Clinic Laboratories Newborn Screening Product and Solutions
Table 29. Mayo Clinic Laboratories Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 31. GeneDx Company Information, Head Office, and Major Competitors
Table 32. GeneDx Major Business
Table 33. GeneDx Newborn Screening Product and Solutions
Table 34. GeneDx Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GeneDx Recent Developments and Future Plans
Table 36. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 37. PreventionGenetics Major Business
Table 38. PreventionGenetics Newborn Screening Product and Solutions
Table 39. PreventionGenetics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. PreventionGenetics Recent Developments and Future Plans
Table 41. SYNLAB Company Information, Head Office, and Major Competitors
Table 42. SYNLAB Major Business
Table 43. SYNLAB Newborn Screening Product and Solutions
Table 44. SYNLAB Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. SYNLAB Recent Developments and Future Plans
Table 46. Cordlife Company Information, Head Office, and Major Competitors
Table 47. Cordlife Major Business
Table 48. Cordlife Newborn Screening Product and Solutions
Table 49. Cordlife Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Cordlife Recent Developments and Future Plans
Table 51. BGI Genomics Company Information, Head Office, and Major Competitors
Table 52. BGI Genomics Major Business
Table 53. BGI Genomics Newborn Screening Product and Solutions
Table 54. BGI Genomics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. BGI Genomics Recent Developments and Future Plans
Table 56. Berry Genomics Company Information, Head Office, and Major Competitors
Table 57. Berry Genomics Major Business
Table 58. Berry Genomics Newborn Screening Product and Solutions
Table 59. Berry Genomics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Berry Genomics Recent Developments and Future Plans
Table 61. Annaroad Company Information, Head Office, and Major Competitors
Table 62. Annaroad Major Business
Table 63. Annaroad Newborn Screening Product and Solutions
Table 64. Annaroad Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Annaroad Recent Developments and Future Plans
Table 66. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 67. Jiajian Medical Testing Major Business
Table 68. Jiajian Medical Testing Newborn Screening Product and Solutions
Table 69. Jiajian Medical Testing Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Jiajian Medical Testing Recent Developments and Future Plans
Table 71. Genesky Company Information, Head Office, and Major Competitors
Table 72. Genesky Major Business
Table 73. Genesky Newborn Screening Product and Solutions
Table 74. Genesky Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Genesky Recent Developments and Future Plans
Table 76. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 77. Weihansi Biomedical Technology Major Business
Table 78. Weihansi Biomedical Technology Newborn Screening Product and Solutions
Table 79. Weihansi Biomedical Technology Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 81. Global Newborn Screening Revenue (USD Million) by Players (2021-2026)
Table 82. Global Newborn Screening Revenue Share by Players (2021-2026)
Table 83. Breakdown of Newborn Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Newborn Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Newborn Screening Players
Table 86. Newborn Screening Market: Company Product Type Footprint
Table 87. Newborn Screening Market: Company Product Application Footprint
Table 88. Newborn Screening New Market Entrants and Barriers to Market Entry
Table 89. Newborn Screening Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Newborn Screening Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Newborn Screening Consumption Value Share by Type (2021-2026)
Table 92. Global Newborn Screening Consumption Value Forecast by Type (2027-2032)
Table 93. Global Newborn Screening Consumption Value by Application (2021-2026)
Table 94. Global Newborn Screening Consumption Value Forecast by Application (2027-2032)
Table 95. North America Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Newborn Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Newborn Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Newborn Screening Upstream (Raw Materials)
Table 126. Global Newborn Screening Typical Customers
Table 1. Global Newborn Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Newborn Screening Consumption Value by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Table 3. Global Newborn Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Newborn Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Newborn Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Newborn Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Newborn Screening Product and Solutions
Table 10. Thermo Fisher Scientific Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Revvity Company Information, Head Office, and Major Competitors
Table 13. Revvity Major Business
Table 14. Revvity Newborn Screening Product and Solutions
Table 15. Revvity Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Revvity Recent Developments and Future Plans
Table 17. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 18. Quest Diagnostics Major Business
Table 19. Quest Diagnostics Newborn Screening Product and Solutions
Table 20. Quest Diagnostics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. MedGenome Company Information, Head Office, and Major Competitors
Table 22. MedGenome Major Business
Table 23. MedGenome Newborn Screening Product and Solutions
Table 24. MedGenome Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. MedGenome Recent Developments and Future Plans
Table 26. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 27. Mayo Clinic Laboratories Major Business
Table 28. Mayo Clinic Laboratories Newborn Screening Product and Solutions
Table 29. Mayo Clinic Laboratories Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 31. GeneDx Company Information, Head Office, and Major Competitors
Table 32. GeneDx Major Business
Table 33. GeneDx Newborn Screening Product and Solutions
Table 34. GeneDx Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. GeneDx Recent Developments and Future Plans
Table 36. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 37. PreventionGenetics Major Business
Table 38. PreventionGenetics Newborn Screening Product and Solutions
Table 39. PreventionGenetics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. PreventionGenetics Recent Developments and Future Plans
Table 41. SYNLAB Company Information, Head Office, and Major Competitors
Table 42. SYNLAB Major Business
Table 43. SYNLAB Newborn Screening Product and Solutions
Table 44. SYNLAB Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. SYNLAB Recent Developments and Future Plans
Table 46. Cordlife Company Information, Head Office, and Major Competitors
Table 47. Cordlife Major Business
Table 48. Cordlife Newborn Screening Product and Solutions
Table 49. Cordlife Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Cordlife Recent Developments and Future Plans
Table 51. BGI Genomics Company Information, Head Office, and Major Competitors
Table 52. BGI Genomics Major Business
Table 53. BGI Genomics Newborn Screening Product and Solutions
Table 54. BGI Genomics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. BGI Genomics Recent Developments and Future Plans
Table 56. Berry Genomics Company Information, Head Office, and Major Competitors
Table 57. Berry Genomics Major Business
Table 58. Berry Genomics Newborn Screening Product and Solutions
Table 59. Berry Genomics Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Berry Genomics Recent Developments and Future Plans
Table 61. Annaroad Company Information, Head Office, and Major Competitors
Table 62. Annaroad Major Business
Table 63. Annaroad Newborn Screening Product and Solutions
Table 64. Annaroad Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Annaroad Recent Developments and Future Plans
Table 66. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 67. Jiajian Medical Testing Major Business
Table 68. Jiajian Medical Testing Newborn Screening Product and Solutions
Table 69. Jiajian Medical Testing Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Jiajian Medical Testing Recent Developments and Future Plans
Table 71. Genesky Company Information, Head Office, and Major Competitors
Table 72. Genesky Major Business
Table 73. Genesky Newborn Screening Product and Solutions
Table 74. Genesky Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Genesky Recent Developments and Future Plans
Table 76. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 77. Weihansi Biomedical Technology Major Business
Table 78. Weihansi Biomedical Technology Newborn Screening Product and Solutions
Table 79. Weihansi Biomedical Technology Newborn Screening Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 81. Global Newborn Screening Revenue (USD Million) by Players (2021-2026)
Table 82. Global Newborn Screening Revenue Share by Players (2021-2026)
Table 83. Breakdown of Newborn Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Newborn Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Newborn Screening Players
Table 86. Newborn Screening Market: Company Product Type Footprint
Table 87. Newborn Screening Market: Company Product Application Footprint
Table 88. Newborn Screening New Market Entrants and Barriers to Market Entry
Table 89. Newborn Screening Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Newborn Screening Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Newborn Screening Consumption Value Share by Type (2021-2026)
Table 92. Global Newborn Screening Consumption Value Forecast by Type (2027-2032)
Table 93. Global Newborn Screening Consumption Value by Application (2021-2026)
Table 94. Global Newborn Screening Consumption Value Forecast by Application (2027-2032)
Table 95. North America Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Newborn Screening Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Newborn Screening Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Newborn Screening Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Newborn Screening Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Newborn Screening Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Newborn Screening Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Newborn Screening Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Newborn Screening Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Newborn Screening Upstream (Raw Materials)
Table 126. Global Newborn Screening Typical Customers
LIST OF FIGURES
Figure 1. Newborn Screening Picture
Figure 2. Global Newborn Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Newborn Screening Consumption Value Market Share by Type in 2025
Figure 4. Genetic Sequencing
Figure 5. Hearing Screening
Figure 6. Pulse Oximetry
Figure 7. Others
Figure 8. Global Newborn Screening Consumption Value by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Newborn Screening Consumption Value Market Share by Screening Purpose in 2025
Figure 10. Core Condition Screening
Figure 11. Expanded Condition Screening
Figure 12. Global Newborn Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Newborn Screening Consumption Value Market Share by Service Model in 2025
Figure 14. Public Health Program
Figure 15. Consumer
Figure 16. Others
Figure 17. Global Newborn Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Newborn Screening Consumption Value Market Share by Application in 2025
Figure 19. Public Hospitals Picture
Figure 20. Private Hospitals Picture
Figure 21. Others Picture
Figure 22. Global Newborn Screening Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Newborn Screening Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Newborn Screening Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Newborn Screening Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Newborn Screening Consumption Value Market Share by Region in 2025
Figure 27. North America Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Newborn Screening Revenue Share by Players in 2025
Figure 34. Newborn Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Newborn Screening by Player Revenue in 2025
Figure 36. Top 3 Newborn Screening Players Market Share in 2025
Figure 37. Top 6 Newborn Screening Players Market Share in 2025
Figure 38. Global Newborn Screening Consumption Value Share by Type (2021-2026)
Figure 39. Global Newborn Screening Market Share Forecast by Type (2027-2032)
Figure 40. Global Newborn Screening Consumption Value Share by Application (2021-2026)
Figure 41. Global Newborn Screening Market Share Forecast by Application (2027-2032)
Figure 42. North America Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 52. France Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Newborn Screening Consumption Value Market Share by Region (2021-2032)
Figure 59. China Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 62. India Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 76. Newborn Screening Market Drivers
Figure 77. Newborn Screening Market Restraints
Figure 78. Newborn Screening Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Newborn Screening Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Newborn Screening Picture
Figure 2. Global Newborn Screening Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Newborn Screening Consumption Value Market Share by Type in 2025
Figure 4. Genetic Sequencing
Figure 5. Hearing Screening
Figure 6. Pulse Oximetry
Figure 7. Others
Figure 8. Global Newborn Screening Consumption Value by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Newborn Screening Consumption Value Market Share by Screening Purpose in 2025
Figure 10. Core Condition Screening
Figure 11. Expanded Condition Screening
Figure 12. Global Newborn Screening Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Newborn Screening Consumption Value Market Share by Service Model in 2025
Figure 14. Public Health Program
Figure 15. Consumer
Figure 16. Others
Figure 17. Global Newborn Screening Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Newborn Screening Consumption Value Market Share by Application in 2025
Figure 19. Public Hospitals Picture
Figure 20. Private Hospitals Picture
Figure 21. Others Picture
Figure 22. Global Newborn Screening Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Newborn Screening Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Newborn Screening Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Newborn Screening Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Newborn Screening Consumption Value Market Share by Region in 2025
Figure 27. North America Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Newborn Screening Revenue Share by Players in 2025
Figure 34. Newborn Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Newborn Screening by Player Revenue in 2025
Figure 36. Top 3 Newborn Screening Players Market Share in 2025
Figure 37. Top 6 Newborn Screening Players Market Share in 2025
Figure 38. Global Newborn Screening Consumption Value Share by Type (2021-2026)
Figure 39. Global Newborn Screening Market Share Forecast by Type (2027-2032)
Figure 40. Global Newborn Screening Consumption Value Share by Application (2021-2026)
Figure 41. Global Newborn Screening Market Share Forecast by Application (2027-2032)
Figure 42. North America Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 52. France Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Newborn Screening Consumption Value Market Share by Region (2021-2032)
Figure 59. China Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 62. India Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Newborn Screening Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Newborn Screening Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Newborn Screening Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Newborn Screening Consumption Value (2021-2032) & (USD Million)
Figure 76. Newborn Screening Market Drivers
Figure 77. Newborn Screening Market Restraints
Figure 78. Newborn Screening Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Newborn Screening Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
